Schedule 13D ownership disclosure

REPARE THERAPEUTICS INC

Common Shares · CUSIP: 760273102

Event date: 2024-12-20

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • MPM BioVentures 2014, L.P.Reported CIK 0001609492

    Shares: 1,731,575.00 · Class: 4.1%

  • MPM BioVentures 2014 (B), L.P.Reported CIK 0001609493

    Shares: 115,492.00 · Class: 0.3%

  • MPM Asset Management Investors BV2014 LLCReported CIK 0001609495

    Shares: 59,603.00 · Class: 0.1%

  • UBS Oncology Impact Fund L.P.Reported CIK 0001691428

    Shares: 1,394,186.00 · Class: 3.3%

  • MPM BioVentures 2014 GP LLCReported CIK 0001765091

    Shares: 1,847,067.00 · Class: 4.3%

  • MPM BioVentures 2014 LLCReported CIK 0001765021

    Shares: 1,906,670.00 · Class: 4.5%

  • Oncology Impact Fund (Cayman) Management L.P.Reported CIK 0001721036

    Shares: 1,394,186.00 · Class: 3.3%

  • MPM BioImpact LLCReported CIK 0001687078

    Shares: 1,394,186.00 · Class: 3.3%

  • ANSBERT GADICKEReported CIK 0001134655

    Shares: 3,300,856.00 · Class: 7.8%

  • LUKE EVNINReported CIK 0001134657

    Shares: 0.00 · Class: 4.5%

  • Todd FoleyReported CIK 0001473930

    Shares: 1,906,670.00 · Class: 4.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-24-030162
Form type
SCHEDULE 13D/A
Filer
MPM BioVentures 2014, L.P.
CIK
CIK 1609492
Filed
Dec 26, 2024
Reporting period
Dec 20, 2024
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub